Healthcare

CSL Ltd (ASX: CSL) attracted investor attention during the afternoon trading session on 4 August 2026, with its shares trading at AUD 128.09, representing a gain of 3.05%, or AUD 3.79, for the day. While the stock recorded a notable daily advance, it remains …

For a market that has often struggled to nurture homegrown medical-technology success stories, 4DMedical’s ascent has become one of the more closely watched narratives in the healthcare sector, and its latest surge underlined the enthusiasm around it.

EBR Systems, developer of a pioneering wireless cardiac-pacing technology, fell 8.62 per cent on 3 August, ranking among the biggest decliners in the All Ordinaries on a day when the broader market advanced. For a stock that has been a favourite of investors seeking …

Mayne Pharma has been at the centre of one of the more dramatic corporate sagas on the ASX, and on 3 August its shares surged 10.15 per cent to $2.93 as investors returned to the stock. The rally came as the pharmaceutical company pressed …

Eureka Group Holdings Ltd (ASX:EGH) is an Australian-listed company focused on the ownership and operation of affordable seniors’ accommodation communities. The company’s shares were trading at$0.705, recording a decline of 4.08%, highlighting a recent movement in market sentiment toward the stock. Share price movements …

Vitrafy Life Sciences Limited (ASX:VFY) reported progress across scientific validation, product manufacturing, commercial partnerships and United States expansion during FY26.

PYC Therapeutics Ltd (ASX:PYC) shares traded at $1.935, up 6.32%, at the time of writing on 4 August 2026, placing the stock among the day’s stronger performers on the ASX. Listed on the Australian Securities Exchange, the company positions itself as a clinical-stage biotechnology …